Ascend (Drug Discovery)

Rockville, MD · Founded 2021 · Privately Held (backing)

Developer of a biotechnology platform designed to support the development and commercialization of advanced therapies. Ascend (Drug Discovery) is based in Rockville, MD and was founded in 2021. Its last known valuation is $151 million. It has raised $194 million.

Last price · $/share

—

Implied valuation

$150.9M

Total raised

$194.3M

Last round

—

How much has Ascend (Drug Discovery) raised?

$194.3Macross 0 recorded rounds

Free account

More of Ascend (Drug Discovery) with a free account

·The complete investor list: 13 names
·Watch Ascend (Drug Discovery): the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Ascend (Drug Discovery) investors

13 investors are on record for Ascend (Drug Discovery), including DCVC, Cathay Capital, Digitalis Ventures and Deerfield Management. By type, the record holds 5 venture capital firms, 1 hedge fund and 1 private equity firm.

For fundraisers

Raising for a company like Ascend (Drug Discovery)?

13 investors have backed Ascend (Drug Discovery).

See all 13 investors →

Frequently asked about Ascend (Drug Discovery)

How much has Ascend (Drug Discovery) raised?: Ascend (Drug Discovery) has raised $194.3M in total across 0 recorded funding rounds.